Abstract
Disturbances in metabolism are at the root of a variety of human afflictions and complex diseases. Although many of the genes that contribute to these conditions have been identified since the completion of the human genome by genome-wide association studies, it is still unclear for many of these genetic variants how they disrupt cellular processes. In this chapter we shall present the concept of genome-wide association studies with metabolomics. These studies show how combining two highly sophisticated biochemical measurement methods, genetics and metabolomics, applied to only a small amount of blood, can reveal deep insights into the genetic makeup of the human body’s metabolic capacities. In addition to providing functional insights into the genetic basis of metabolic traits and complex diseases, study of what we call “genetically determined metabotypes” is a way to understand an individual’s uniqueness. These genetically determined metabotypes may modify the risk of an individual to develop a disease, the response to medication and therapy, and the reaction to environmental challenges and thereby help to develop highly targeted, personalized therapies and enable novel types of treatments or prevent adverse drug reactions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mootha VK, Hirschhorn JN (2010) Inborn variation in metabolism. Nat Genet 42:97–98
WTCCC (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678
Hindorff LA, Sethupathy P, Junkins HA et al (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106:9362–9367
Silventoinen K, Sammalisto S, Perola M et al (2003) Heritability of adult body height: a comparative study of twin cohorts in eight countries. Twin Res 6:399–408
Maher B (2008) Personal genomes: the case of the missing heritability. Nature 456:18–21
Yang J, Benyamin B, McEvoy BP et al (2010) Common SNPs explain a large proportion of the heritability for human height. Nat Genet 42:565–569
Gieger C, Geistlinger L, Altmaier E et al (2008) Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 4:e1000282
Tanaka T, Shen J, Abecasis GR et al (2009) Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 5:e1000338
Hicks AA, Pramstaller PP, Johansson A et al (2009) Genetic determinants of circulating sphingolipid concentrations in European populations. PLoS Genet 5:e1000672
Illig T, Gieger C, Zhai G et al (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42:137–141
Nicholson G, Rantalainen M, Li JV et al (2011) A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection. PLoS Genet 7:e1002270
Suhre K, Shin SY, Petersen AK et al (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477:54–60
Suhre K, Wallaschofski H, Raffler J et al (2011) A genome-wide association study of metabolic traits in human urine. Nat Genet 43:565–569
Kottgen A, Pattaro C, Boger CA et al (2010) New loci associated with kidney function and chronic kidney disease. Nat Genet 42:376–384
Chambers JC, Zhang W, Lord GM et al (2010) Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 42:373–375
Doring A, Gieger C, Mehta D et al (2008) SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 40:430–436
Caulfield MJ, Munroe PB, O’Neill D et al (2008) SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 5:e197
Schadt EE, Lamb J, Yang X et al (2005) An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 37:710–717
Chen Y, Zhu J, Lum PY et al (2008) Variations in DNA elucidate molecular networks that cause disease. Nature 452:429–435
Yang X, Deignan JL, Qi H et al (2009) Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat Genet 41:415–423
Teslovich TM, Musunuru K, Smith AV et al (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466:707–713
Link E, Parish S, Armitage J et al (2008) SLCO1B1 variants and statin-induced myopathy–a genomewide study. N Engl J Med 359:789–799
Klein TE, Chang JT, Cho MK et al (2001) Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics research network and knowledge base. Pharmacogenomics J 1:167–170
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Suhre, K. (2012). Genome-Wide Association Studies with Metabolomics. In: Suhre, K. (eds) Genetics Meets Metabolomics. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1689-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1689-0_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1688-3
Online ISBN: 978-1-4614-1689-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)